Gene · 11335
CBX3: chromobox 3
12 sourcesgene-search-2026-11-11-0.2.0
Cite this record
ConductScience Library. CBX3: chromobox 3. Genes, record 11335. Release gene-search-2026-11-11-0.2.0, 11 Nov 2026. https://conductscience.org/library/genes/11335
On this page
Gene
Proteins1
Reviewed human proteins whose Swiss-Prot entry states the gene.
| UniProt entry | Protein | Length | Structures | Gene stated in |
|---|---|---|---|---|
| Q13185 | Chromobox protein homolog 3 | 183 | 8 | Ensembl, GeneID, HGNC |
Source UniProt
Patents55
Patents whose sequence listing contains this protein's exact sequence. A patent can list a sequence without claiming it.
| Publication | Published | SEQ ID NO | Protein | Source |
|---|---|---|---|---|
| EP 4650780 A2 | 2025-11-19 | 6207 | Q13185 | Espacenet |
| EP 4641201 A2 | 2025-10-29 | 5972 | Q13185 | Espacenet |
| JP 2025517969 A | 2025-06-12 | 5972 | Q13185 | Espacenet |
| JP 2025517970 A | 2025-06-12 | 6207 | Q13185 | Espacenet |
| US 12285484 B2 | 2025-04-29 | 288 | Q13185 | Espacenet |
| US 12285484 B2 | 2025-04-29 | 291 | Q13185 | Espacenet |
| US 12285484 B2 | 2025-04-29 | 292 | Q13185 | Espacenet |
| US 12285484 B2 | 2025-04-29 | 293 | Q13185 | Espacenet |
| US 12285484 B2 | 2025-04-29 | 294 | Q13185 | Espacenet |
| US 12285484 B2 | 2025-04-29 | 295 | Q13185 | Espacenet |
1 to 10 of 55
See all 55 patentsDrugs0
Drugs a ChEMBL mechanism record says act on the gene's protein, through Open Targets.
None in this release.
Trials0
Trials of those drugs. A trial joins the gene only through a drug that acts on it.
None in this release.
NIH grants1,401
NIH grants whose papers are about the gene, through NIH's grant-paper links.
| Grant | Title | CBX3 papers | Newest fiscal year |
|---|---|---|---|
| P30CA008748 | Cancer Center Support Grant | 14 | 2025 |
| P30CA016672 | Cancer Center Support Grant | 10 | 2025 |
| P30DK084567 | Mayo Center for Cell Signaling in Gastroenterology | 9 | 2025 |
| ZIABC010309 | Nuclear Architecture and Disease | 8 | 2025 |
| P30CA006927 | Comprehensive Cancer Center Program at Fox Chase | 6 | 2025 |
| P30CA016086 | Cancer Center Support Grant | 6 | 2025 |
| P30CA010815 | Consolidated Basic Cancer Research Program | 5 | 2025 |
| P30CA014089 | University of Southern California Norris Comprehensive Cancer Center Support Grant (CCSG) | 5 | 2025 |
| P30CA086862 | Cancer Center Support Grant | 5 | 2025 |
| R01AR045203 | D4Z4 Coding Transcripts and FSHD | 4 | 2025 |
1 to 10 of 1,401Source NIH's project files
See all 1,401 nih grantsPapers1,834
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Minimal CBX3-Derived UCOE Confers Long-Term Resistance to Transgene Silencing in Human iPSCs During Neuronal Differentiation. | Int J Mol Sci | 2026 | 42794476 | PubTator, text mining | PubMed |
| CBX3 aggravates nucleus pulposus cell apoptosis and extracellular matrix degradation in vitro via repressing SESN2-mediated mitophagy in an H3K9me3-dependent manner. | Mol Biol Rep | 2026 | 42776360 | PubTator, text mining | PubMed |
| tRNA-derived small RNAs in vascular smooth muscle cell phenotypic switching and vascular remodelling. | Mol Biol Rep | 2026 | 42658340 | PubTator, text mining | PubMed |
| CTCF primes repressive chromatin for rapid BRCA1/BARD1 recruitment to drive homologous recombination repair of DNA double-strand breaks. | Nucleic Acids Res | 2026 | 42475683 | PubTator, text mining | PubMed |
| HP1γ promotes the progression of colorectal cancer through interaction with RBPJ of the Notch signaling pathway. | Cell Biol Toxicol | 2026 | 42387182 | PubTator, text mining | PubMed |
| Multilayered control of mRNA delivery to cell protrusions drives localized mini-cytoplasm establishment for stress-induced cell activation. | Nat Commun | 2026 | 42365002 | PubTator, text mining | PubMed |
| Manipulating CD38 ectoenzymatic activity revitalizes regulatory T cells via deacetylase Sirt-1 in immune thrombocytopenia. | J Thromb Haemost | 2026 | 42362030 | PubTator, text mining | PubMed |
| Transcriptomic profiling of epigenetic regulators and metabolic reprogramming in human cholangiocarcinoma. | Front Cell Dev Biol | 2026 | 42326014 | PubTator, text mining | PubMed |
| CBX3 promotes epithelial-mesenchymal transition in synovial sarcoma via the SHH signaling pathway. | Am J Cancer Res | 2026 | 42004054 | PubTator, text mining | PubMed |
| Protein arginine methyltransferases in cancer: mechanisms, functions, and therapeutic opportunities. | J Biomed Sci | 2026 | 41928257 | PubTator, text mining | PubMed |
1 to 10 of 1,834
See all 1,834 papersSources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this gene from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/genes/v1/11335
GET https://conductscience.org/api/genes/v1/11335/patents?page=2